有毒的大结肠:一种罕见的表现和新的治疗方法
Adrienne P Davis1, Jennifer M Schuh1,2, Janice Bitong1,2
1Medical College of Wisconsin Milwaukee Wisconsin USA.
JPGN reports
|February 16, 2026
概括
一名患有毒性大结肠 (TM) 的儿科患者通过转向循环结肠切除术实现了解决. 这种方法为治疗儿科TM提供了切除术的替代方案,特别是在偏远结肠不运动的情况下.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 结肠直肠手术 结肠直肠手术
背景情况:
- 毒性大结肠 (TM) 是结肠炎症的一种罕见但严重的并发症.
- 标准治疗通常涉及全腹切除术和末端结节术,这在儿科患者中可能是病态的.
研究的目的:
- 评价转向环结肠切除术作为儿科有毒巨结肠的替代性手术管理的有效性.
- 评估结肠运动性研究在诊断儿童TM的潜在原因方面的作用.
主要方法:
- 一个14岁的男性有毒巨结肠的案例报告.
- 诊断工作包括便培养,直肠活检,阳门测量和结肠运动性研究.
- 手术干预涉及一个转向循环静脉切除术.
主要成果:
- 诊断测试排除了感染性原因 (Clostridium difficile) 和结构异常 (希尔斯普隆病,门).
- 结肠机动性研究揭示了远端结肠机动性,与慢性便秘和缩相一致.
- 患者的有毒大结肠在转向循环结肠切除术后消失,避免了全腹切除术.
结论:
- 转向循环结肠切除术可以成为治疗儿科有毒巨结肠的全腹切除术的有效替代方案.
- 预先升级的结肠溶液可能是结肠静脉切除术的宝贵补充,用于管理相关的结肠动性.
- 这种方法可能会减少儿科患者的发病率,而不是标准的胆管切除术.
相关概念视频
Pharmaceutical Poisoning: Treatment Strategies
17
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
17
Drugs for Treatment of Ulcerative Colitis in IBD
544
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
544
Inflammatory Bowel Disease IV: Pharmacological Management
795
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
795
Drugs for Treatment of Diarrhea-Predominant IBS
754
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
754
Chronic Bowel Disorders: Introduction
817
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
915
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915


